Dual functionality nanobioconjugates targeting intracellular bacteria in cancer cells with enhanced antimicrobial activity

Abstract Bacterial drug resistance has emerged as a serious global threat mandating the development of novel methodologies that allow facile modulation of antimicrobial action in a controlled fashion. Conjugating antibiotics to nanoparticles helps to meet this goal by increasing the drug’s overall a...

Full description

Bibliographic Details
Main Authors: Rohini Singh, Smita Patil, Neetu Singh, Shalini Gupta
Format: Article
Language:English
Published: Nature Publishing Group 2017-07-01
Series:Scientific Reports
Online Access:https://doi.org/10.1038/s41598-017-06014-4
id doaj-3731b35f52ed4b44bbd66e2e500ec66b
record_format Article
spelling doaj-3731b35f52ed4b44bbd66e2e500ec66b2020-12-08T00:57:01ZengNature Publishing GroupScientific Reports2045-23222017-07-017111010.1038/s41598-017-06014-4Dual functionality nanobioconjugates targeting intracellular bacteria in cancer cells with enhanced antimicrobial activityRohini Singh0Smita Patil1Neetu Singh2Shalini Gupta3Department of Chemical Engineering, Indian Institute of Technology DelhiCentre for Biomedical Engineering, Indian Institute of Technology DelhiCentre for Biomedical Engineering, Indian Institute of Technology DelhiDepartment of Chemical Engineering, Indian Institute of Technology DelhiAbstract Bacterial drug resistance has emerged as a serious global threat mandating the development of novel methodologies that allow facile modulation of antimicrobial action in a controlled fashion. Conjugating antibiotics to nanoparticles helps to meet this goal by increasing the drug’s overall avidity, bioavailability and easier internalisation into mammalian cells, targeting bacteria that otherwise escape antibacterial action by host cell-localisation. We used polymyxin B sulfate (PMB) and sushi peptide as model drugs against Gram-negative bacteria and established their enhanced antimicrobial activity on Escherichia coli (E. coli) cells after conjugation to gold nanoparticles (AuNPs). The efficacy of the bioconjugates was also tested on Salmonella typhi (S. typhi) bacteria infected into cervical cancer cells (HeLa) and further improved through specific targeting via folate receptors. Our results demonstrate significantly lower inhibitory concentration values for sushi-NP assemblies as compared to free drug, especially at optimal drug loading levels. No major cytotoxicity was observed in mammalian cells alone.https://doi.org/10.1038/s41598-017-06014-4
collection DOAJ
language English
format Article
sources DOAJ
author Rohini Singh
Smita Patil
Neetu Singh
Shalini Gupta
spellingShingle Rohini Singh
Smita Patil
Neetu Singh
Shalini Gupta
Dual functionality nanobioconjugates targeting intracellular bacteria in cancer cells with enhanced antimicrobial activity
Scientific Reports
author_facet Rohini Singh
Smita Patil
Neetu Singh
Shalini Gupta
author_sort Rohini Singh
title Dual functionality nanobioconjugates targeting intracellular bacteria in cancer cells with enhanced antimicrobial activity
title_short Dual functionality nanobioconjugates targeting intracellular bacteria in cancer cells with enhanced antimicrobial activity
title_full Dual functionality nanobioconjugates targeting intracellular bacteria in cancer cells with enhanced antimicrobial activity
title_fullStr Dual functionality nanobioconjugates targeting intracellular bacteria in cancer cells with enhanced antimicrobial activity
title_full_unstemmed Dual functionality nanobioconjugates targeting intracellular bacteria in cancer cells with enhanced antimicrobial activity
title_sort dual functionality nanobioconjugates targeting intracellular bacteria in cancer cells with enhanced antimicrobial activity
publisher Nature Publishing Group
series Scientific Reports
issn 2045-2322
publishDate 2017-07-01
description Abstract Bacterial drug resistance has emerged as a serious global threat mandating the development of novel methodologies that allow facile modulation of antimicrobial action in a controlled fashion. Conjugating antibiotics to nanoparticles helps to meet this goal by increasing the drug’s overall avidity, bioavailability and easier internalisation into mammalian cells, targeting bacteria that otherwise escape antibacterial action by host cell-localisation. We used polymyxin B sulfate (PMB) and sushi peptide as model drugs against Gram-negative bacteria and established their enhanced antimicrobial activity on Escherichia coli (E. coli) cells after conjugation to gold nanoparticles (AuNPs). The efficacy of the bioconjugates was also tested on Salmonella typhi (S. typhi) bacteria infected into cervical cancer cells (HeLa) and further improved through specific targeting via folate receptors. Our results demonstrate significantly lower inhibitory concentration values for sushi-NP assemblies as compared to free drug, especially at optimal drug loading levels. No major cytotoxicity was observed in mammalian cells alone.
url https://doi.org/10.1038/s41598-017-06014-4
work_keys_str_mv AT rohinisingh dualfunctionalitynanobioconjugatestargetingintracellularbacteriaincancercellswithenhancedantimicrobialactivity
AT smitapatil dualfunctionalitynanobioconjugatestargetingintracellularbacteriaincancercellswithenhancedantimicrobialactivity
AT neetusingh dualfunctionalitynanobioconjugatestargetingintracellularbacteriaincancercellswithenhancedantimicrobialactivity
AT shalinigupta dualfunctionalitynanobioconjugatestargetingintracellularbacteriaincancercellswithenhancedantimicrobialactivity
_version_ 1724395550117199872